Trial Identifier: | D8664R00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03193060 |
Start Date: | September 2017 |
Primary Completion Date: | December 2019 |
Study Completion Date: | December 2019 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |
China | shijiazhuang, China |